학술논문
Rationale and design of a multicentre, 12-week, randomised, double-blind, placebo-controlled, parallel-group, investigator-initiated trial to investigate the efficacy and safety of elobixibat for chronic constipation
Document Type
article
Author
Takuma Higurashi; Jun Arimoto; Atsushi Nakajima; Keisuke Ariyoshi; Shunsuke Oyamada; Masataka Taguri; Masato Yoneda; Takaomi Kessoku; Takashi Kobayashi; Anna Ozaki; Tomoyuki Iwasaki; Takeo Kurihashi; Michihiro Iwaki; Kunihiro Hosono; Eiji Sakai; Kosuke Tanaka; Atsushi Yamamoto; Kota Takahashi; Yuki Kasai; Tsutomu Yoshihara; Noboru Misawa; Takayuki Kato; Akiko Fuyuki; Hideyuki Chiba; Machiko Nakatogawa; Ayao Suzuki; Noritoshi Kobayashi; Yasushi Ichikawa
Source
BMJ Open, Vol 12, Iss 5 (2022)
Subject
Language
English
ISSN
2044-6055